Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2012
05/31/2012US20120136153 Camptothecin analogs and methods of preparation thereof
05/31/2012US20120136150 4-(3-Butynyl)Aminopyrimidine Derivatives as Pest Control Agents for Agricultural and Horticultural Use
05/31/2012US20120136024 3-Substituted-2-(arlyalkyl)-1-azabicycloalkanes and Methods of Use Thereof
05/31/2012US20120136012 Amino tetrahydro-pyridopyrimidine pde10 inhibitors
05/31/2012US20120136008 Pyrido[4,3-b]indoles and methods of use
05/31/2012US20120136000 Tri-cyclic pyrazolopyridine kinase inhibitors
05/31/2012US20120135999 Compounds and methods for antiviral treatment
05/31/2012US20120135998 Compounds for treating respiratory syncytial virus infections
05/31/2012US20120135989 Azaindole derivative
05/31/2012US20120135987 Novel phenylimidazole derivatives as pde10a enzyme inhibitors
05/31/2012US20120135986 Bicyclic Heteroaryl Compounds
05/31/2012US20120135981 Novel substituted triazole and imidazole derivatives as gamma secretase modulators
05/31/2012US20120135977 Ether benzotriazole derivatives
05/31/2012US20120135968 Tetracycline Compounds
05/31/2012US20120135961 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
05/31/2012US20120135885 Methods and Kits Using Extended Rhodamine Dyes
05/31/2012US20120135421 Methods for the identification of phosphatidylinositol kinase interacting molecules and for the purification of phosphatidylinositol kinase proteins
05/31/2012US20120135089 E3 ligase inhibitors
05/31/2012US20120132899 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same
05/31/2012CA2818898A1 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and mmanufacture
05/31/2012CA2818889A1 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
05/31/2012CA2818050A1 Bicyclic gpr119 modulators
05/31/2012CA2817629A1 Salts and crystalline forms of an apoptosis-inducing agent
05/31/2012CA2815029A1 Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as jak inhibitors
05/30/2012EP2457913A2 Heteroaryl compounds, compositions thereof, and methods of treatment therewith
05/30/2012EP2457912A1 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element
05/30/2012EP2457901A1 Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
05/30/2012EP2456763A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders
05/30/2012EP2456761A2 Potent small molecule inhibitors of autophagy and methods of use thereof
05/30/2012EP2456757A2 Hdac inhibitors and therapeutic methods using the same
05/30/2012EP2456307A1 Isoform selective phospholipase d inhibitors
05/30/2012EP1771453B1 Hepatitis c inhibitor dipeptide analogs
05/30/2012EP1670787B1 Cytokine inhibitors
05/30/2012CN102482292A Modulators of 5-ht receptors and methods of use thereof
05/30/2012CN102482279A Organic electronic device, compounds for same, and terminal
05/30/2012CN102482276A 杂环化合物及其用途 Heterocyclic compounds and their use
05/30/2012CN102482275A Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer
05/30/2012CN102482274A 具有被取代了的蒽环结构和吡啶并吲哚环结构的化合物以及有机电致发光器件 Having a substituted anthracene ring structure and a pyridoindole ring structure and a compound of the organic electroluminescent device
05/30/2012CN102482273A 5-phenyl-[1,2,4 ]triazolo[1,5-a]pyridin-2-yl carboxamides as jak inhibitors
05/30/2012CN102482257A Apoptosis signal-regulating kinase inhibitors
05/30/2012CN102482234A Nitrogen-containing compound and pharmaceutical composition
05/30/2012CN102482231A 磺酰胺和磺基肟-取代的二芳基-二氢嘧啶酮和其应用 Sulfonamides and sulfonamide oxime - substituted diaryl - dihydro-pyrimidone and their applications
05/30/2012CN102482227A 作为γ分泌酶调节剂的取代的三唑和咪唑衍生物 As the γ-secretase modulators substituted triazole and imidazole derivatives
05/30/2012CN102482221A 作为katii抑制剂的双环和三环化合物 Bicyclic and tricyclic compounds as inhibitors katii
05/30/2012CN102482217A Bi - Or Tricyclic Sterically Hindered Alkoxyamines And Process For Their Preparation
05/30/2012CN102477035A 一种从伏康树籽中提取纯化它勃宁的清洁化工艺 An extract from the seeds of the tree-volt Kang purified it 勃宁 of clean technology
05/30/2012CN102477034A 氨基酸修饰的1-甲基-β-咔啉-3-羧酸及其合成方法和应用 1-methyl-amino acid modification -β- carboline-3-carboxylic acids and the synthesis method and application
05/30/2012CN102050822B Method for extracting tabersonine from voacanga seed
05/30/2012CN102002041B Phenanthroindolizidine alkaloid derivates and salt thereof as well as application of anti-cancer activity
05/30/2012CN101921272B Method for extracting and separating laburnine
05/30/2012CN101657418B Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists
05/30/2012CN101611014B Acylaminopyrazoles as FGFR inhibitors
05/30/2012CN101573361B Novel aminopyrimidine derivative as plk1 inhibitor
05/30/2012CN101573358B Pyrido (2, 3-D) pyrimidinone compounds and their use as PI3 inhibitors
05/30/2012CN101544638B Lact-pyrondridin and its pharmaceutical composition
05/30/2012CN101400657B Polycyclic cinnamide derivative
05/29/2012US8188281 Azaindoles useful as inhibitors of JAK and other protein kinases
05/29/2012US8188279 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
05/29/2012US8188271 Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
05/29/2012US8188120 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
05/29/2012US8188114 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof
05/29/2012US8188113 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies
05/29/2012US8188109 Benzoquinolizinium salt derivatives as anticancer agents
05/29/2012US8188095 Gyrase inhibitors and uses thereof
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2523196C Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals
05/29/2012CA2496585C Novel 1,4-diazabicycloalkane derivatives, their preparation and use
05/29/2012CA2496127C Piperidinyl compounds that selectively bind integrins
05/29/2012CA2463966C Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/24/2012WO2012068450A1 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
05/24/2012WO2012068234A2 Antiviral compounds
05/24/2012WO2012068204A1 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012WO2012067965A1 Nampt and rock inhibitors
05/24/2012WO2012067963A1 Nampt inhibitors
05/24/2012WO2012067425A1 Novel compound for organic electronic material and organic electroluminescent device using the same
05/24/2012WO2012066486A1 Compound ethyl 8-oxo-9-[3-(1h-benzimidazol-2-yloxy)phenyl]-4,5,6,7,8,9-hexahydro-2h-pyrrolo[3,4-b]quinoline-3-carboxylate, salt, crystalline form, cocrystal, formulation, processes for preparation, application as medicaments, pharmaceutical compositions and new use particularly as inhibitor of aurora kinases
05/24/2012WO2012066234A1 Novel indolizine derivatives, and preparation and therapeutic use thereof
05/24/2012WO2012066061A1 Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
05/24/2012WO2012065963A2 Novel antiviral compounds
05/24/2012WO2012065546A1 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
05/24/2012WO2012065297A1 3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
05/24/2012WO2012009472A3 Structure, synthesis, and applications for oligo phenylene ethynylenes (opes)
05/24/2012US20120130075 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
05/24/2012US20120130070 Compounds having npy y5 receptor antagonistic activity
05/24/2012US20120129884 Photochemotherapeutic heterocyclic agents having antiproliferative and antineoplastic activity
05/24/2012US20120129872 Fused heteroaryl inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129868 Poly (adp-ribose) polymerase (parp) inhibitors
05/24/2012US20120129856 Compounds, compositions and methods useful for cholesterol mobilisation
05/24/2012US20120129852 Azaindazoles as kinase inhibitors and use thereof
05/24/2012US20120129851 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
05/24/2012US20120129849 Deuterated serine-threonine protein kinase modulators
05/24/2012US20120129846 Gamma secretase modulators
05/24/2012US20120129836 Imidazole derivatives as PDE10A enzyme inhibitors
05/24/2012US20120126220 Compound having substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device
05/24/2012CA2818542A1 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
05/24/2012CA2818389A1 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
05/24/2012CA2818279A1 Novel indolizine derivatives, and preparation and therapeutic use thereof
05/24/2012CA2817840A1 Antiviral compounds
05/24/2012CA2817785A1 Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
05/24/2012CA2817165A1 Novel antiviral compounds
1 ... 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 ... 646